A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient

Atherosclerosis

Volumn 130, Issue 1-2, 1997, Pages 153-160

  Okubo, Minoru ^a   Hasegawa, Yukihiro ^b   Aoyama, Yoshiko ^a   Murase, Toshio ^a  

^a Okinaka Memorial Institute for Medical Research   (Japan)

^b Div of Endocrinology and Metabolism   (Japan)

Author keywords

apolipoprotein C II; apolipoprotein E4; donor splice site; exon skipping; hypertriglyceridemia

Indexed keywords

APOLIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; CASE REPORT; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030931322     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)06061-3     Document Type: Article

References (36)

1. Brunzell JD. Apolipoprotein C-II deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). The Metabolic Basis of Inherited Disease, 6th edn. New York:McGraw-Hill, 1989;1172.
2. Fojo SS, Brewer HB. Hypertriglyceridemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992;231:669.
3. Jackson CL, Bruns GAP, Breslow JL. Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII. Proc Natl Acad Sci USA 1984;81:2945.
4. Wei CF, Tsao YK, Robberson DL, Gotto Jr. AM, Brown K, Chan L. The structure of the human apolipoprotein C-II gene. J Biol Chem 1985;260:15211.
5. Das HK, Jackson CL, Miller DA, Leff T, Breslow JL. The human apolipoprotein C-II gene sequence contains a novel chromosome 19-specific minisatellite in its third intron. J Biol Chem 1987;262:4787.
6. Fojo SS, Law SW, Brewer Jr. HB. The human preproapolipoprotein C-II gene. FEBS lett 1987;213:221.
7. 26-Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (Apo CII-Wakayama). Biochem Biophys Res Commun 1993;193:1174.
8. Reina M, Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res 1992;33:1823.
9. Ohno M, Ishibashi S, Nakao K, Nozue T, Nonomura K, Yamada N, Aburatani H, Shimano H, Murase T. A neonatal case of apolipoprotein C-II deficiency. Eur J Pediatr 1989;148:550.
10. Hegele RA, Breckenridge WC, Cox DW, Maguire GF, Little JA, Connelly PW. Interaction between variant apolipoproteins C-II and E affects plasma lipoprotein concentrations. Arterioscler Thromb 1991;11:1303.
11. Ishibashi S, Yamada N, Shimano H, Mori N, Mokuno H, Gotohda T, Kawakami M, Murase T, Takaku F. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J Biol Chem 1990;265:3040.
12. Murase T, Yamada N, Ohsawa N, Kosaka K, Morita S, Yoshida S. Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism 1980;29:666.
13. Murase T, Cattran DC, Rubinstein B, Steiner G. Inhibition of lipoprotein lipase by uremic plasma. A possible cause of hypertriglyceridemia. Metabolism 1975;24:1279.
14. Norman AM, Floyd JL, Meredith AL, Harper PS. Presymptomatic detection and prenatal diagnosis for myotonic dystrophy by means of linked DNA markers. J Med Genet 1989;26:750.
15. MacKenzie AE, MacLeod HL, Leblond SC, Monteith N, Lahey D, Korneluk RG. DNA polymorphism and linkage disequilibrium within the apolipoprotein CII locus on human chromosome 19. Hum Hered 1991;41:188.
16. Hegele RA, Tu L. Variation within intron 3 of the apolipoprotein CII gene. Nucl Acid Res 1991;19:3162.
17. Weber J L, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388.
18. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545.
19. Kamboh MI, Ferrell RE, Kottke B. Genetic studies of human apolipoproteins. V. a rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res 1988;29:1535.
20. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989;86:2617.
21. Parkinson DB, Thakker RV. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nature Genet 1992;1:149.
22. Gotoda T, Yamada N, Murase T, Inaba T, Ishibashi S, Shimano H, Koga S, Yazaki Y, Furuichi Y, Takaku F. Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency. J Biol Chem 1991;266:24757.
23. +1 to t substitution in a 5′-splice site causing Fabry disease. Genomics 1992;12:643.
24. Padgett RA, Grabowski PJ, Konarska MM, Seiler S, Sharp PA. Splicing of messenger RNA precursors. Annu Rev Biochem 1986;55:1119.
25. Xiong W, Li WH, Posner I, Yamamura T, Yamamoto A, Gotto Jr. AM, Chan L. No severe bottleneck during human evolution: Evidence from two apolipoprotein C-II deficiency alleles. Am J Hum Genet 1991;48:383.
26. Hamburg) of a patient with Apo C-II deficiency. J Clin Invest 1988;82:1489.
27. Humphries SE, Berg K, Gill L, Cumming AM, Robertson FW, Stalenhoef AFH, Williamson R, Borresen AL. The gene for apolipoprotein C-II is closely linked to the gene for apolipoprotein E on chromosome 19. Clin Genet 1984;26:389.
28. Hamburg: clinical and biochemical features and Hph I restriction enzyme polymorphism. Eur J Clin Invest 1992;22:88.
29. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promotor and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 1993;90:4562.
30. Okubo M, Murase T. Hypertriglyceridemia and low HDL-cholesterol in Japanese patients with non-insulin-dependent diabetes mellitus. Diabetes 1996;45:S123.
31. Mahley RW, Rail Jr. SC. Type III hyperlipoproteinemia (Dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds). The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York:McGraw-Hill, 1995; 1953.
32. Mann WA, Meyer N, Weber W, Rinninger F, Greten H, Beisiegel U. Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes. Eur J Clin Invest 1995;25:880.
33. Ghiselli G, Schaeffer EJ, Zech LA, Gregg RE, Brewer Jr. HB. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest 1982;70:474.
34. Kuusi T, Taskinen MR, Solakivi T, Kauppinen-Makelin R. Role of apolipoprotein E and C in type V hyperlipoproteinemia. J Lipid Res 1988;29:293.
35. Ma Y, Ooi TC, Liu MS, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res 1994;35:1066.
36. St. Michael: familial apolipoprotein CII deficiency associated with premature vascular disease. J Clin Invest 1987; 80:1597.